Cover Image
市場調查報告書

凝血/止血分析設備的全球市場 - 2021年為止的預測:臨床檢驗分析設備,POC檢驗分析設備

Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021

出版商 MarketsandMarkets 商品編碼 328478
出版日期 內容資訊 英文 169 Pages
訂單完成後即時交付
價格
Back to Top
凝血/止血分析設備的全球市場 - 2021年為止的預測:臨床檢驗分析設備,POC檢驗分析設備 Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021
出版日期: 2016年11月22日 內容資訊: 英文 169 Pages
簡介

一般認為凝血分析設備市場將從2016年的29億8000萬美元,擴大到2021年的48億4000萬美元。市場預測在2016年∼2021年間,將以年複合成長率 (CAGR) 10.2%的速度成長。

本報告提供全球凝血/止血分析設備市場相關調查分析,提供您市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 凝血分析設備市場概要

第5章 凝血/止血分析設備的全球市場:概要

  • 簡介
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會
    • 課題

第6章 凝血分析設備的全球市場:各產品

  • 簡介
  • 臨床檢驗分析設備
  • POC檢驗分析設備

第7章 凝血分析設備的全球市場:檢查別

  • 簡介
  • 凝血酵素原時間 (PT)
  • 纖維蛋白原
  • 活性凝固時間 (ACT)
  • 活化部分凝血活酵素時間 (APTT)
  • D-二聚體
  • 血小板功能
  • 凝血第Xa抗因素
  • 肝素·精蛋白用量反應
  • 其他

第8章 凝血分析設備的全球市場:各技術

  • 簡介
  • 光學的
  • 機械性
  • 電化學
  • 其他

第9章 凝血分析設備的全球市場:患者的醫療環境別

  • 簡介
  • 臨床檢驗分析設備
  • POC檢驗分析設備
  • 其他

第10章 凝血分析設備的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第11章 競爭情形

  • 簡介
  • 策略性概要
  • 市場佔有率分析
  • 競爭情形與趨勢

第12章 企業簡介

  • 簡介
  • ALERE INC.
  • 日本光電工業
  • ROCHE DIAGNOSTICS
  • SIEMENS HEALTHCARE
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC INC.
  • DIAGNOSTICA STAGO SAS
  • HELENA LABORATORIES
  • INSTRUMENTATION LABORATORY
  • INTERNATIONAL TECHNIDYNE CORPORATION (ITC)

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 3255

The coagulation analyzers market is projected to reach USD 4.84 billion by 2021 from USD 2.98 billion in 2016, at a CAGR of 10.2% from 2016 to 2021. The global coagulation analyzers market is segmented based on product, test, technology, end-users and regions. The clinical laboratory analyzers segment is expected to register the highest growth rate in the consumables market, by product, during the forecast period. The high growth in this segment is attributed to the increasing rental agreements and increasing prevalence of autoimmune diseases worldwide. Moreover, high cost of coagulation analyzers and slow adoption of advanced hemostasis instruments in emerging economies is restraining the growth of this market.

Based on end-users, the coagulation analyzers market are classified into clinical laboratories, PoC testing and others. The clinical laboratories segment is expected to account for the largest share of the global coagulation analyzers market in 2016. Increasing prevalence of CVD's and the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories will drive the growth of this market.

Geographically, the coagulation analyzers market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by increasing aging population and increasing prevalence of CVD's.

The major factors contributing to the growth of the coagulation analyzers market include increasing high incidences of CVD's, increasing blood related disorders, and rising geriatric population. On the other hand, slow adoption of advanced hemostasis instruments in emerging economies and high cost of fully automated hemostasis analyzers are the major factors restraining the growth of this market. The high growth potential in the Asian region provides growth opportunities to players in the coagulation analyzers market.

The major players in this market include are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.).

Research Coverage:

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach and levels of output in order to remain successful in the coagulation analyzers market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the coagulation analyzers market. The report analyses the coagulation analyzers market by product, test type, technology, and end users.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the coagulation analyzers market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the coagulation analyzers market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various coagulation analyzers across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the coagulation analyzers market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
    • 2.1.1. KEY DATA FROM SECONDARY SOURCES
  • 2.2. PRIMARY DATA
    • 2.2.1. KEY DATA FROM PRIMARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. COAGULATION ANALYZERS MARKET OVERVIEW

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing Prevalence of Cardiovascular Diseases and Blood Disorders
      • 5.2.1.2. Rising Aging Population
      • 5.2.1.3. Development of High-sensitivity PoC Coagulation Testing
      • 5.2.1.4. Increasing Laboratory Automation
    • 5.2.2. RESTRAINT
      • 5.2.2.1. High Cost of Fully Automated Coagulation Analyzers
    • 5.2.3. OPPORTUNITY
      • 5.2.3.1. Emerging Markets
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Slow Adoption of Advanced Hemostasis Instruments in Emerging Economies

6. COAGULATION ANALYZERS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. CLINICAL LABORATORY ANALYZERS
    • 6.2.1. CONSUMABLES
      • 6.2.1.1. Reagents
      • 6.2.1.2. Standards, Controls, and Calibrations
    • 6.2.2. SYSTEMS
      • 6.2.2.1. Automated Systems
      • 6.2.2.2. Semiautomated Systems
      • 6.2.2.3. Manual Systems
  • 6.3. POINT-OF-CARE TESTING ANALYZERS

7. COAGULATION ANALYZERS MARKET, BY TEST

  • 7.1. INTRODUCTION
  • 7.2. PROTHROMBIN TIME TESTING
  • 7.3. FIBRINOGEN TESTING
  • 7.4. ACTIVATED CLOTTING TIME TESTING
  • 7.5. ACTIVATED PARTIAL THROMBOPLASTIN TIME TESTING
  • 7.6. D-DIMER TESTING
  • 7.7. PLATELET FUNCTION TESTS
  • 7.8. ANTI-FACTOR XA TESTS
  • 7.9. HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT
  • 7.10. OTHER COAGULATION TESTS

8. COAGULATION ANALYZERS MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. OPTICAL TECHNOLOGY
  • 8.3. MECHANICAL TECHNOLOGY
  • 8.4. ELECTROCHEMICAL TECHNOLOGY
  • 8.5. OTHER TECHNOLOGIES

9. COAGULATION ANALYZERS MARKET, BY PATIENT CARE SETTING

  • 9.1. INTRODUCTION
  • 9.2. CLINICAL LABORATORIES
  • 9.3. POINT-OF-CARE TESTING
  • 9.4. OTHER END USERS

10. COAGULATION ANALYZERS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. U.K.
    • 10.3.3. FRANCE
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA (ROA)
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. STRATEGIC OVERVIEW
  • 11.3. MARKET SHARE ANALYSIS
  • 11.4. COMPETITIVE SITUATION AND TRENDS
    • 11.4.1. PRODUCT LAUNCHES
    • 11.4.2. EXPANSIONS
    • 11.4.3. AGREEMENTS
    • 11.4.4. OTHER DEVELOPMENTS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. ALERE INC.
  • 12.3. NIHON KOHDEN CORPORATION
  • 12.4. ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.)
  • 12.5. SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG)
  • 12.6. SYSMEX CORPORATION
  • 12.7. THERMO FISHER SCIENTIFIC INC.
  • 12.8. DIAGNOSTICA STAGO SAS
  • 12.9. HELENA LABORATORIES
  • 12.10. INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP)
  • 12.11. INTERNATIONAL TECHNIDYNE CORPORATION (ITC)

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: EXAMPLES OF POC COAGULATION ANALYZERS BY LEADING PLAYERS
  • TABLE 2: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 3: CLINICAL LABORATORY ANALYZERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 4: CLINICAL LABORATORY ANALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 6: CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR CONSUMABLES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: CONSUMABLES MARKET SIZE FOR REAGENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: CONSUMABLES MARKET SIZE FOR STANDARDS, CONTROLS, AND CALIBRATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR SYSTEMS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 10: CLINICAL LABORATORY ANALYZERS MARKET SIZE FOR SYSTEMS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: SEMIAUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: MANUAL SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: POC TESTING ANALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 16: PROTHROMBIN TIME TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: ACT TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: APTT TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: D-DIMER TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: PLATELET FUNCTION TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: ANTI-FACTOR XA TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: HEPARIN & PROTAMINE DOSE RESPONSE TESTS FOR ACT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: OTHER COAGULATION TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 26: OPTICAL TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: MECHANICAL TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: ELECTROCHEMICAL TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: OTHER TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 31: CLINICAL LABORATORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: POINT-OF-CARE TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: OTHER END USERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: LIST OF RELATED CONFERENCES HELD IN NORTH AMERICA
  • TABLE 36: NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 38: NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 39: NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 41: U.S.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 42: U.S.: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 43: U.S.: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 44: CANADA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 45: CANADA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 46: CANADA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 52: GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 53: GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 54: GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 55: U.K.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 56: U.K.: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 57: U.K.: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 58: FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 59: FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 60: FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 61: ITALY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 62: ITALY: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 63: ITALY: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 64: SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 65: SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 66: SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 67: ROE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 68: ROE: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 69: ROE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 70: ASIA: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 71: ASIA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 72: ASIA: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 73: ASIA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 74: ASIA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 75: CHINA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 76: CHINA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 77: CHINA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 78: JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 79: JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 80: JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 81: INDIA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 82: INDIA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 83: INDIA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 84: ROA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 85: ROA: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 86: ROA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 87: ROW: COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 88: ROW: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 89: ROW: COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 90: ROW: COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2014-2021 (USD MILLION)
  • TABLE 91: ROW: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 92: GROWTH STRATEGY MATRIX, 2014-2016
  • TABLE 93: PRODUCT LAUNCHES, 2014-2016
  • TABLE 94: EXPANSIONS, 2014-2016
  • TABLE 95: AGREEMENTS, 2014-2016
  • TABLE 96: OTHER DEVELOPMENTS, 2014-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL COAGULATION ANALYZERS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION
  • FIGURE 4: COAGULATION ANALYZERS MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: COAGULATION ANALYZERS MARKET: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD BILLION)
  • FIGURE 8: GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2016 VS. 2021 (USD BILLION)
  • FIGURE 9: GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD BILLION)
  • FIGURE 10: GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD BILLION)
  • FIGURE 11: GLOBAL COAGULATION ANALYZERS MARKET SIZE, BY REGION
  • FIGURE 12: GLOBAL COAGULATION ANALYZERS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: OPTICAL TECHNOLOGY SEGMENT TO DOMINATE THE GLOBAL COAGULATION ANALYZERS MARKET IN 2016
  • FIGURE 14: ASIAN MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: COAGULATION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES
  • FIGURE 16: COAGULATION ANALYZERS MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 17: CLINICAL LABORATORY ANALYZERS WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: CONSUMABLES WILL CONTINUE TO DOMINATE THE CLINICAL LABORATORY ANALYZERS MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: REAGENTS WILL CONTINUE TO DOMINATE THE CONSUMABLES MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: AUTOMATED SYSTEMS WILL CONTINUE TO DOMINATE THE COAGULATION SYSTEMS MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: PROTHROMBIN TIME TESTING SEGMENT WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PROTHROMBIN TIME TESTING MARKET IN 2016
  • FIGURE 23: OPTICAL TECHNOLOGY TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: CLINICAL LABORATORIES SEGMENT WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
  • FIGURE 25: NORTH AMERICA TO DOMINATE THE GLOBAL COAGULATION ANALYZER MARKET IN 2016
  • FIGURE 26: THE COAGULATION ANALYZERS MARKET IN ASIA IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 27: NORTH AMERICA: COAGULATION ANALYZERS MARKET SNAPSHOT
  • FIGURE 28: THE U.S. IS ESTIMATED TO DOMINATE THE NORTH AMERICAN COAGULATION ANALYZERS MARKET IN 2016
  • FIGURE 29: CLINICAL LABORATORY ANALYZERS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN COAGULATION ANALYZERS MARKET IN 2016
  • FIGURE 30: CLINICAL LABORATORY ANALYZERS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE U.S. COAGULATION ANALYZERS MARKET IN 2016
  • FIGURE 31: CLINICAL LABORATORY ANALYZERS ARE EXPECTED TO DOMINATE THE COAGULATION ANALYZERS MARKET IN CANADA DURING THE FORECAST PERIOD
  • FIGURE 32: GERMANY IS ESTIMATED TO DOMINATE THE EUROPEAN COAGULATION ANALYZERS MARKET IN 2016
  • FIGURE 33: POC TESTING ANALYZERS TO REGISTER HIGHEST GROWTH IN THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD
  • FIGURE 34: CLINICAL LABORATORY ANALYZERS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE COAGULATION ANALYZERS MARKET IN GERMANY IN 2016
  • FIGURE 35: CLINICAL LABORATORY ANALYZERS TO COMMAND THE COAGULATION ANALYZERS PRODUCTS MARKET IN THE U.K. IN 2016
  • FIGURE 36: CLINICAL LABORATORY ANALYZERS ESTIMATED TO DOMINATE THE FRENCH MARKET IN 2016
  • FIGURE 37: CLINICAL LABORATORY ANALYZERS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ITALIAN COAGULATION ANALYZERS MARKET IN 2016
  • FIGURE 38: COAGULATION ANALYZERS FOR POC TESTING SEGMENT TO GROW AT THE HIGHEST RATE IN THE SPANISH MARKET
  • FIGURE 39: CLINICAL LABORATORY ANALYZERS TO HOLD LARGEST SHARE IN ROE IN 2016
  • FIGURE 40: ASIA: COAGULATION ANALYZERS MARKET SNAPSHOT
  • FIGURE 41: CHINA IS ESTIMATED TO DOMINATE THE ASIAN COAGULATION ANALYZERS MARKET IN 2016
  • FIGURE 42: CLINICAL LABORATORY ANALYZERS TO BE THE LARGEST PRODUCT SEGMENT IN ASIAN MARKET IN 2016
  • FIGURE 43: CLINICAL LABORATORY ANALYZERS TO BE THE LARGEST PRODUCT SEGMENT IN THE CHINESE COAGULATION ANALYZERS MARKET IN 2016
  • FIGURE 44: CLINICAL LABORATORY ANALYZERS TO HOLD LARGEST SHARE IN JAPANESE MARKET IN 2016
  • FIGURE 45: POC TESTING ANALYZERS TO WITNESS HIGHEST GROWTH IN THE INDIAN MARKET DURING THE FORECAST PERIOD
  • FIGURE 46: CLINICAL LABORATORY ANALYZERS, THE MAJOR PRODUCT SEGMENT IN ROA IN 2016
  • FIGURE 47: SOUTH AMERICA, CENTRAL AMERICA, AND THE CARIBBEAN TO DOMINATE THE ROW COAGULATION ANALYZERS MARKET IN 2016
  • FIGURE 48: CLINICAL LABORATORY ANALYZERS EXPECTED TO DOMINATE THE ROW MARKET, BY PRODUCT, IN 2016
  • FIGURE 49: PRODUCT LAUNCH WAS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE COAGULATION ANALYZERS MARKET
  • FIGURE 50: COAGULATION ANALYZERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 51: GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS
  • FIGURE 52: COMPANY SNAPSHOT: ALERE INC.
  • FIGURE 53: COMPANY SNAPSHOT: NIHON KOHDEN CORPORATION
  • FIGURE 54: COMPANY SNAPSHOT: ROCHE DIAGNOSTICS
  • FIGURE 55: COMPANY SNAPSHOT: SIEMENS AG
  • FIGURE 56: COMPANY SNAPSHOT: SYSMEX CORPORATION
  • FIGURE 57: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC.
Back to Top